<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        205-325-08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BUDINIDE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BUDESONIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        µg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Nasal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Nasal spray
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        200
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Spray Pump
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        30.8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R01AD05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>BUDINIDE contains a medicine called budesonide. This belongs to a group of medicines called corticosteroids.</p><ul><li>Corticosteroids help to prevent inflammation.</li><li>BUDINIDE is used to treat the effects of allergies, such as hay fever, and inflammation inside the nose (rhinitis).</li><li>It can also stop these effects from coming on.</li><li>It is also used to treat small growths inside the nose (nasal polyps).</li></ul><p>You must talk to a doctor if you do not feel better or if you feel worse after 14 days.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use BUDINIDE:&nbsp; </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to budesonide or any of the other ingredients of this medicine (listed in section 6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are under 18 years of age.</p><p>If you are not sure if this applies to you, talk to your doctor or pharmacist &nbsp;before using BUDINIDE.</p><p>&nbsp;</p><p><strong>Warnings and Precautions</strong></p><p>Talk to your doctor or pharmacist before using BUDINIDE if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have TB (tuberculosis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have a chest infection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have reduced liver function.</p><p>Contact your doctor if you experience blurred vision or other visual disturbances.</p><p>If you are not sure if either of the above apply to you, talk to your doctor or pharmacist before using BUDINIDE.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and BUDINIDE </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This&nbsp;is because BUDINIDE can affect the way some medicines work and some medicines can have an effect on BUDINIDE and your doctor may wish to monitor you carefully.</p><p>In particular, talk to your doctor if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are taking medicines to treat fungal infections (such as itraconazole or ketoconazole).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are taking HIV medicines (such as ritonavir or cobicistat-containing products).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have been taking steroid tablets. Your doctor may ask you to take fewer of them after starting to use BUDINIDE. If you notice any unusual effects as a result of this, tell your doctor.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are taking oestrogens and contraceptive steroids.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you get pregnant while using BUDINIDE, <strong>talk to your doctor straight away</strong>.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>BUDINIDE is not likely to affect you being able to drive or use any tools or machines</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Read the label to remind you of what they said.</p><p>&nbsp;</p><p><strong>How much BUDINIDE to use </strong></p><p><strong>Allergies such as hay fever</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The recommended dose for adults and the elderly is two sprays of BUDINIDE into each nostril in the morning. Alternatively, your doctor may ask you to take one spray of BUDINIDE into each nostril every morning and evening.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This may be reduced by your doctor once your symptoms have improved.</p><p>&nbsp;</p><p>It is important to use BUDINIDE regularly. Try to use it before you come into contact with whatever causes the allergy. For example, pollen is what causes hay fever, so you will be more at risk outdoors.</p><p>&nbsp;</p><p><strong>Nasal polyps</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The recommended dose is one spray of BUDINIDE into each nostril every morning and evening.</p><p>&nbsp;</p><p>Treatment for allergies such as hay fever and for nasal polyps can continue for up to 3 months.</p><p><br /><strong>Use in children&nbsp;</strong></p><p>BUDINIDE is not recommended for use in children.</p><p><strong>Instructions for use</strong></p><p><strong>1.Priming the nozzle </strong>Before using BUDINIDE for the first time, you must prime the nozzle (that is, fill it with the medicine). To do this:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<img alt="" width="191" height="319" src="data:image/jpeg;base64,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" /></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shake the bottle and remove the protective cap.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hold the bottle upright as shown in the picture.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pump the nozzle up and down several times (5 to 10 times), spraying into the air until you see an even mist.</p><p>The priming effect remains for about 24 hours. If you leave a gap of more than a day before the next dose, you will need to prime the nozzle again. This time spray it into the air just once.</p><p><strong>2. Using&nbsp;BUDINIDE&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<img alt="" width="192" height="304" src="data:image/jpeg;base64,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" /></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blow your nose. Shake the bottle. Remove the protective cap.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hold the bottle as shown in the picture.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Put the tip of the nozzle into your nostril, as shown. Spray once (or more if the doctor has told you to). Use the spray in the other nostril in the same way. Note, you do not need to breathe in at the same time as you spray.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wipe the nozzle with a clean tissue and replace the protective cap. <strong>Store the bottle in an upright position. </strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>3. Cleaning the nozzle</strong></p><p>It is best to clean the plastic nozzle of BUDINIDE regularly. Also clean it if you notice that the spray is not coming out as it should. If this happens, first check the nozzle is primed with medicine (see &ldquo;Priming the nozzle&rdquo; above). If after priming the nozzle again the pump is still not working, clean the nozzle as follows:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the plastic nozzle with a clean tissue and wash it in warm (not hot) water.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rinse the nozzle thoroughly, dry it and then replace it on the top of the bottle. Never try to unblock the nozzle by using a pin or other sharp object.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prime the nozzle again (by filling it with medicine) before use.</p><p>&nbsp;</p><p><strong>Additional information about using BUDINIDE</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are about to have an <strong>operation</strong> or during times of <strong>stress</strong>, please tell the doctor that you use BUDINIDE. The doctor may ask you to take steroid tablets as well, particularly if you have been taking a high dose of BUDINIDE, or a similar medicine, for a long time.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Eye problems</strong>: If you have an allergy which is also causing eye problems, you may need to take another medicine as well.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Long-term treatment</strong>: If you use BUDINIDE every day for a long time, your doctor will need to have a regular check of the inside of your nose (the nasal mucosa).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Children and adolescents</strong>: If a child or adolescent is prescribed BUDINIDE and uses a high dose for a long time, the doctor will need to check how well they are growing.</p><p><strong>&nbsp;</strong></p><p><strong>If you use more BUDINIDE than you should</strong></p><p>It is important that you take your dose as stated on the pharmacist&rsquo;s label or as advised by your doctor. You should use only as much as your doctor recommends; using more or less may make your symptoms worse. If you take too many doses of BUDINIDE, talk to your doctor or pharmacist straight away.</p><p>&nbsp;</p><p><strong>If you forget to use BUDINIDE</strong></p><p>If you forget to take a dose, take it as soon as you remember. However, if it is almost time to take the next dose, wait until then. Do not use a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop using BUDINIDE</strong></p><p>You may not notice any effects of the medicine for the first few days. Do not stop using this medicine. Keep taking the medicine as you have been told to. If you still feel no different after a few more days, talk to your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, BUDINIDE<sup> </sup>can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>If any of the following happen to you, stop using BUDINIDE and talk to your doctor straight away:</strong></p><ul><li>Skin rash, itching, lumpy rash (hives), blistering of the skin. Swelling of your face, lips, tongue or throat (this may make it difficult to swallow). These are uncommon, affecting less than 1 in 100 people.</li><li>Severe allergic reaction. This is rare, affecting less than 1 in 1000 people.</li><li>In addition to the above, sudden wheezing and/or feeling faint may occur. It is not known how often these occur; however they are very unlikely. If any of the above occurs, you may be having an allergic reaction.&nbsp;&nbsp;</li></ul><p><strong>Other possible side effects: Common (may affect up to 1 in 10 people)</strong></p><ul><li>Occasional sneezing, dry nose, or stinging in your nose. These can happen straight after using BUDINIDE.</li><li>Slight bleeding from the nose.</li></ul><p><strong>Uncommon (may affect up to 1 in 100 people)</strong></p><ul><li>Muscle cramps.</li></ul><p><strong>Rare (may affect up to 1 in 1000 people) </strong></p><ul><li>Slowing of the rate of growth of children and adolescents. Corticosteroids can affect the normal production of steroid hormones in your body, particularly if you use high doses for a long time. This is much less likely to happen with inhaled corticosteroids than with corticosteroid tablets.</li><li>Perforation of the membrane separating the nostrils (the nasal septum).</li><li>Nasal ulcer.</li><li>Loss of voice.</li><li>Bruising of the skin.</li><li>Blurred vision.</li></ul><p><strong>Very rare (may affect up to 1 in 10,000 people) </strong></p><ul><li>Sore patches on the inside of the nose.</li></ul><p><strong>Not known (frequency cannot be estimated from the available data) </strong></p><ul><li>Glaucoma (increased pressure in the eye).</li><li>Cataract.</li></ul><p>If any of these side effects occur, they usually go away after a short time.</p><p><strong>If you get any side effects, talk to your doctor, pharmacist. This includes any possible side effects not listed in this leaflet.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use BUDINIDE after the expiry date which is stated on the package.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30 &deg;C.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not freeze or refrigerate.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store the bottle in an upright position.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use within 3 months of opening the bottle. You may find it helpful to write on this leaflet when you first opened the bottle:</p><p>Date bottle opened&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;&hellip;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each dose contains budesonide (Ph. Eur) 50 micrograms.</p><p>The other ingredients:</p><p>Sodium Carboxymethylcellulose , Microcrystalline Cellulose , Potassium Sorbate , Glucose , Polysorbate 80 , Disodium Edetate , Hydrochloric acid N , Purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                BUDINIDE Packaged in amber coloured glass bottle with assembled pump containing white to off white suspension.

Pack size: Each bottle contains 200 doses.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)</p><p>P.O. Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: <u>contact@riyadhpharma.com</u></p><p><em>For any information about this medicinal product, please contact the local representative of marketing authorization holder:</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: <u>marketing@riyadhpharma.com</u></p><p><strong>Manufacturer:</strong></p><p>Mipharm S.p.A.</p><p>20141 Milan-Italy</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was issued in (03/2018),
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي بودينايد على دواء يسمى بوديسونايد. ينتمي إلى مجموعة من الأدوية تسمى الستيرويدات القشرية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;تساعد الستيرويدات القشرية على منع الالتهاب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;يستخدم بودينايد لمعالجة آثار الحساسية، مثل حمى القش، والتهاب داخل الأنف (التهاب مخاطية الأنف).</p><p dir="RTL">&middot;&nbsp; &nbsp; ويمكنها أيضا إيقاف هذه الآثار من الظهور.</p><p dir="RTL">&middot;&nbsp;&nbsp; كما أنها تستخدم لعلاج زوائد صغيرة داخل الأنف (اللحميات الأنفية).</p><p>يجب عليك التحدث إلى الطبيب إذا كنت لا تشعر بالتحسن أو إذا كنت تشعر أسوأ بعد 14 يوما.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم بودينايد</strong><strong>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية من بوديسونايد أو أي من المكونات الأخرى لهذا الدواء ( المدرجة في القسم 6 ).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان عمرك أقل من 18 سنة.</p><p dir="RTL">إذا لم تكن متأكدا مما إذا كان هذا ينطبق عليك، تحدث مع طبيبك أو الصيدلي قبل استخدام بودينايد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي قبل استخدام بودينايد إذا كان:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك السل .</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك عدوى في الصدر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك انخفاض في وظائف الكبد.</p><p dir="RTL">اتصل بطبيبك إذا واجهت عدم وضوح في الرؤية أو اضطرابات بصرية أخرى.</p><p dir="RTL">إذا لم تكن متأكدا مما إذا كان أي مما سبق ينطبق عليك، تحدث إلى طبيبك أو الصيدلي قبل استخدام بودينايد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى و بودينايد</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تستخدم أو قد استخدمت مؤخرا أو قد تستخدم أي أدوية أخرى. وهذا يشمل الأدوية التي تشتريها دون وصفة طبية والأدوية العشبية. وذلك لأن بودينايد يمكن أن يؤثر على الطريقة التي تعمل بها بعض الأدوية وبعض الأدوية يمكن أن يكون لها تأثير على بودينايد وقد يرغب طبيبك في مراقبتك بعناية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">على وجه الخصوص، تحدث مع طبيبك إذا :</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; كنت تتناول أدوية لعلاج الالتهابات الفطرية (مثل إتراكونازول أو كيتوكونازول).</p><p>.&nbsp; &nbsp;&nbsp;كنت تتناول أدوية فيروس نقص المناعة البشرية (مثل ريتونافير أو المنتجات المحتوية على كوبيسيستات).&nbsp;</p><p dir="RTL">&middot;&nbsp; &nbsp; كنت تتناول أقراص الستيرويد. قد يطلب منك طبيبك تناول عدد أقل منهم بعد البدء في استخدام بودينايد. إذا لاحظت أي آثار غير عادية نتيجة لذلك، أخبر طبيبك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;كنت تتناول الإستروجين وستيرويدات منع الحمل.</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp; إذا کنتي حاملا أو مرضعة، تفکرين أنكي قد تکونين حاملا أو تخططين لإرضاع طفلك، اطلبي من الطبیب أو الصیدلي الحصول علی المشورة قبل استخدام ھذا الدواء.</p><p dir="RTL">&middot;&nbsp;&nbsp; إذا كنتي حاملا أثناء استخدام بودينايد، <strong>تحدثي مع طبيبك على الفور</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">من غير المحتمل أن يؤثر بودينايد على القدرة على قيادة أو استخدام أي أدوات أو آلات .</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما استخدام هذا الدواء تماما كما قال لك الطبيب أو الصيدلي. تحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL">اقرأ الملصق لتذكيرك بما وصفوه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>جرعة بودينايد </strong></p><p dir="RTL"><strong>الحساسية مثل حمى القش</strong></p><p dir="RTL">&middot;&nbsp;&nbsp; الجرعة الموصي بها للبالغين وكبار السن بختان من بخاخ بودينايد في كل فتحة أنف في الصباح. بدلا من ذلك، قد يطلب منك الطبيب أن تأخذ بخة واحدة من بودينايد في كل فتحة أنف كل صباح ومساء.</p><p dir="RTL">&middot;&nbsp;&nbsp; قد يقلل طبيبك من هذه الجرعة بمجرد تحسن الأعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL">من المهم استخدام بودينايد بانتظام. حاول استخدامه قبل ظهور مسببات الحساسية. على سبيل المثال، حبوب اللقاح التي &nbsp;تسبب حمى القش، لذلك سوف تكون أكثر عرضة للخطر في الهواء الطلق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اللحميات الأنفية</strong></p><p dir="RTL">&middot;&nbsp;&nbsp; الجرعة الموصي بها هي بخة واحدة من بودينايد في كل فتحة أنف كل صباح ومساء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">علاج أنواع الحساسية مثل حمى القش واللحميات الأنفية يمكن أن يستمر لمدة تصل إلى 3 أشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام في الأطفال</strong></p><p dir="RTL">لا ينصح استخدام بودينايد في الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تعليمات الاستخدام</strong></p><p dir="RTL"><strong>1.&nbsp;&nbsp; </strong><strong>تهيئة الفوهة</strong></p><p dir="RTL">عند استخدام بودينايد للمرة الأولى، يجب أن تهيئ الفوهة (ملؤها بالدواء). لفعل هذا:&nbsp;</p><p dir="RTL">&middot;&nbsp; &nbsp; رج الزجاجة وقم بإزالة الغطاء الواقي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;أمسك الزجاجة بشكل مستقيم كما هو مبين في الصورة.<img src="data:image/png;base64,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" alt="" width="124" height="171" vspace="0" hspace="0" border="0" style="width:124px;height:171px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&middot;&nbsp;&nbsp;ضخ الفوهة لأعلى ولأسفل عدة مرات (5 إلى 10 مرات)، ثم بخ في الهواء حتى ترى رذاذ.</p><p dir="RTL">يبقى تأثير تهيئة الفوهة لمدة 24 ساعة. إذا تركت فترة أكثر من يوم واحد قبل الجرعة التالية، سوف تحتاج إلى تهيئة الفوهة مرة أخرى. هذه المرة بخ في الهواء مرة واحدة فقط.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>2.&nbsp;&nbsp; </strong><strong>استخدام بودينايد</strong></p><p dir="RTL">&middot;&nbsp;&nbsp; اخرج المخاط من أنفك. رج الزجاجة. أزل الغطاء الواقي.</p><p dir="RTL">&middot;&nbsp;&nbsp; أمسك الزجاجة كما هو مبين في الصورة.&nbsp;<img src="data:image/png;base64,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" alt="" width="116" height="147" vspace="0" hspace="0" border="0" style="width:116px;height:147px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&middot;&nbsp;&nbsp; ضع طرف الفوهة في فتحة الأنف، كما هو مبين. بخ مرة واحدة (أو أكثر إذا كان الطبيب قد قال لك). استخدم البخاخ في فتحة الأنف الأخرى بنفس الطريقة. ملاحظة، لا تحتاج إلى الاستنشاق في نفس وقت رش البخاخ.</p><p dir="RTL">&middot;&nbsp;&nbsp; امسح الفوهة بمنديل نظيف <strong>و قم بإعادة الغطاء الواقي. قم بتخزين الزجاجة في وضع رأسي .</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>3.&nbsp;&nbsp; </strong><strong>تنظيف الفوهة</strong></p><p dir="RTL">من الأفضل تنظيف الفوهة البلاستيكية لبودينايد بانتظام. أيضا قم بتنظيفها إذا لاحظت أن الرذاذ لا يخرج كما ينبغي. إذا حدث ذلك، تحقق أولا أن الفوهة مهيأة بالدواء (انظر &quot;تهيئة الفوهة&quot; أعلاه). إذا وجدت بعد تهيئة الفوهة مرة أخرى أن المضخة لا تزال لا تعمل، قم بتنظيف الفوهة على النحو التالي:</p><p>.&nbsp; &nbsp; &nbsp;قم بإزالة الفوھة البلاستیکیة &nbsp;بواسطة منديل نظيف مع غسلها في ماء دافئ (غیر حار).</p><p dir="RTL">&middot;&nbsp; &nbsp; &nbsp;قم بشطف الفوهة جيدا، وجففها ثم قم بإعادتها في أعلى الزجاجة. لا تحاول مطلقا فتح الفوهة باستخدام دبوس أو ألة حادة أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;قم بتهيئة الفوهة مرة أخرى (عن طريق ملؤها بالدواء) قبل الاستخدام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات إضافية حول استخدام بودينايد</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت على وشك إجراء جراحة أو أثناء أوقات التوتر، يرجى إخبار الطبيب بأنك تستخدم بودينايد. قد يطلب منك الطبيب تناول أقراص الستيرويد أيضا، خاصة إذا كنت تتناول جرعة عالية من بودينايد، أو دواء مشابه، لفترة طويلة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مشاكل العيون:</strong> إذا كان لديك حساسية والتي تسبب أيضا مشاكل في العين، قد تحتاج إلى تناول دواء آخر كذلك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>العلاج طويل الأمد:</strong> إذا كنت تستخدم بودينايد يوميا لفترة طويلة ، فسيحتاج طبيبك إلى فحص منتظم لداخل أنفك ( الغشاء المخاطي للأنف ).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الأطفال والمراهقون:</strong> إذا تم وصف بودينايد لطفل أو مراهق ويستخدم جرعة عالية لفترة طويلة، سيحتاج الطبيب للتحقق من كيفية النمو الصحيح لهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا استخدمت بودينايد أكثر مما يجب</strong></p><p dir="RTL">من المهم أن تأخذ جرعتك حسب وصف الصيدلي أو على النحو الموصى به من قبل الطبيب. يجب أن تستخدم فقط بقدر وصف الطبيب. الاستخدام أكثر أو أقل قد يجعل الأعراض أسوأ. إذا تناولت جرعات كثيرة جدا من بودينايد، تحدث مع طبيبك أو الصيدلي على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت استخدام بودينايد</strong></p><p dir="RTL">إذا كنت قد نسيت أن تستخدم جرعة، استخدمها حالما تتذكر. ومع ذلك، إذا كان الوقت قد حان تقريبا لاستخدام الجرعة التالية، انتظر حتى ذلك الحين. لا تستخدم جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن استخدام بودينايد</strong></p><p dir="RTL">قد لا تلاحظ أي آثار للدواء خلال الأيام القليلة الأولى. لا تتوقف عن استخدام هذا الدواء. حافظ على تناول الدواء كما قيل لك. إذا كنت لا تزال لا تشعر بأي اختلاف بعد بضعة أيام أخرى، تحدث مع طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، إسأل طبيبك أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب بودينايد آثارا جانبية، و لكن ليس كل شخص تحدث له.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا حدث أي من الأمور التالية لك، توقف عن استخدام بودينايد وتحدث مع طبيبك على الفور </strong><strong>:</strong></p><ul><li dir="RTL">طفح جلدي، حكة، طفح جلدي متكتل (شرى)، تقرح الجلد. تورم في الوجه والشفتين واللسان أو الحلق (وهذا يجعل صعوبة في البلع). هذه أثار غير شائعة، تؤثر على أقل من 1 من كل 100 شخص.</li><li dir="RTL">رد فعل تحسسي شديد. هذا أمر نادر الحدوث، يؤثر على أقل من 1 من كل 1000 شخص.</li><li dir="RTL">بالإضافة إلى ما سبق، الصفير المفاجئ و / أو الشعور بفقدان الوعي قد تحدث. ومن غير المعروف كم مرة قد تحدث. ومع ذلك فمن غير المرجح جدا حدوثها. إذا حدث أي مما سبق، قد يكون لديك رد فعل تحسسي.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية المحتملة الأخرى: شائعة (قد تؤثر على ما يصل إلى 1 من كل 10 أشخاص)</strong></p><ul><li dir="RTL">العطس من حين لأخر، الأنف الجاف، أو اللدغة في أنفك. يمكن أن يحدث ذلك مباشرة بعد استخدام بودينايد.</li><li dir="RTL">نزیف طفیف من الأنف.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائع (قد تؤثر على ما يصل إلى 1 من كل 100 شخص)</strong></p><ul><li dir="RTL">تشنج العضلات.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادر (قد تؤثر على ما يصل إلى 1 من كل1000 شخص)</strong></p><ul><li dir="RTL">تباطؤ معدل نمو الأطفال والمراهقين. الستيرويدات القشرية يمكن أن تؤثر على الإنتاج الطبيعي من الهرمونات الستيرويدية في الجسم، وخاصة إذا كنت تستخدم جرعات عالية لفترة طويلة. هذا أقل احتمالا بكثير أن يحدث مع الستيرويدات القشرية المستنشقة عن أقراص&nbsp; الستيرويدات القشرية.</li><li dir="RTL">ثقب الغشاء الفاصل بين فتحتي الأنف (الحاجز الأنفي) .</li><li dir="RTL">قرحة الأنف.</li><li dir="RTL">فقدان الصوت.</li><li dir="RTL">كدمات الجلد.</li><li dir="RTL">عدم وضوح الرؤية.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة جدا (قد تؤثر على ما يصل إلى 1 من كل 10000 شخص)</strong></p><ul><li dir="RTL">بقع التهاب في داخل الأنف.</li></ul><p dir="RTL"><strong>غير معروف (لا يمكن تقدير التكرار من البيانات المتاحة)</strong></p><ul><li dir="RTL">المياه الزرقاء (زيادة الضغط في العين).</li><li dir="RTL">الساد (اعتام عدسة العين).</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">إذا حدث أي من هذه الآثار الجانبية، فإنها عادة ما تختفي بعد وقت قصير.</p><p dir="RTL"><strong>إذا حدث أي من الآثار الجانبية بطريقة خطيرة، أو إذا لاحظت أي آثار جانبية غير مذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم بودينايد بعد تاريخ انتهاء الصلاحية المذكور على العبوة .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجمد و لا يوضع في الثلاجة .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في وضع رأسي.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يستخدم في غضون 3 شهور من فتح العبوة. قد تجد أنه من المفيد الكتابة على هذه النشرة تاريخ فتح العبوة :</p><p dir="RTL">تاريخ فتح العبوة :&nbsp; .....................</p><p>التخلص من الأدوية يجب ألا يكون عن طريق مياه الصرف الصحي أو النفايات المنزليه. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبه. هذة التدابير مساعده في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحتوي كل جرعة على بوديسونايد )دستور الأدوية الأوروبي) 50 ميكروجرام&nbsp; .</p><p dir="RTL">المكونات الأخرى:</p><p>صوديوم كاربوكسي ميثيل سيلولوز، ميكروكريستالين السليلوز، سوربات البوتاسيوم، الجلوكوز، بوليسوربات 80، داي صوديوم إديتات، حمض الهيدروكلوريك N، المياه النقية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">بودينايد معبأة في عبوة زجاجية&nbsp; بلون العنبر مجهزة بمضخة وتحتوي على معلق أبيض الى أبيض داكن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>حجم العبوة:</strong> كل عبوة تحتوي على 200 جرعة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة المنتجات الطبية والتجميلية المحدودة (الرياض فارما)</p><p dir="RTL">ص.ب. 442 الرياض 11411</p><p dir="RTL">فاكس: 966112650505+</p><p dir="RTL">البريد الإلكتروني: contact@riyadhpharma.com</p><p dir="RTL"><em>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</em></p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">قسم التسويق</p><p dir="RTL">الرياض</p><p dir="RTL">تلفون: 966112650111+</p><p dir="RTL">البريد الإلكتروني: marketing@riyadhpharma.com</p><p dir="RTL"><strong>المصنع :</strong></p><p dir="RTL">شركة ميفارم إس. بي .إيه .</p><p dir="RTL">20141 ميلان &ndash; إيطاليا .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            صدرت هذه النشرة بتاريخ (3/2018) 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BUDINIDE Nasal Spray 50 µg/dose
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each actuation contains: Budesonide 50 micrograms 

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Nasal spray, white to off white suspension.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Seasonal and perennial allergic rhinitis and vasomotor rhinitis. Treatment of nasal polyps.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p>Dosage should be individualized.</p><p><strong>&nbsp;</strong></p><p><strong>Rhinitis (Adults including the elderly)</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>Recommended start dose</p></td><td style="vertical-align:top"><p>Once daily dosing</p></td><td style="vertical-align:top"><p>Twice daily dosing</p></td></tr><tr><td style="vertical-align:top"><p>200 micrograms per day</p></td><td style="vertical-align:top"><p>Two applications of 50 micrograms into each nostril each morning</p><p><strong>or</strong></p><p>If good effect is achieved, one application of 50 micrograms</p></td><td style="vertical-align:top"><p>One application of 50 micrograms into each nostril morning and evening</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>Nasal Polyps (Adults including the elderly)</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>Recommended start dose</p></td><td style="vertical-align:top"><p>Once daily dosing</p></td><td style="vertical-align:top"><p>Twice daily dosing</p></td></tr><tr><td style="vertical-align:top"><p>200 micrograms per day</p></td><td style="vertical-align:top"><p>Not applicable</p></td><td style="vertical-align:top"><p>One application of 50 micrograms into each nostril morning and evening.</p></td></tr></tbody></table><p>&nbsp;</p><p>The patient should be informed that the full effect of Budinide is not achieved until after a few days treatment. Treatment of seasonal rhinitis should, if possible, start before exposure to allergens. Treatment can be continued for up to 3 months<em>.</em></p><p>Patients should be reminded of the importance of taking this medicine regularly.</p><p>The dose should be titrated to the lowest dose at which effective control of symptoms is achieved.</p><p><strong>Paediatric population</strong>: There are insufficient data to recommend the use of Budinide in children. However, it is unlikely that the risk/benefit ratio in children is different from that in adults.</p><p><strong><u>Method of administration</u></strong></p><p>For nasal inhalation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Special care is demanded in treatment of patients transferred from oral steroids to Budinide where disturbances of the hypothalamic-pituitary-adrenal (HPA) axis could be expected.</p><p>&nbsp;</p><p>Special care is needed in patients with fungal and viral infections of the airways and in patients with active or quiescent pulmonary tuberculosis.</p><p>&nbsp;</p><p>Concomitant treatment of seasonal rhinitis may sometimes be necessary to counteract eye symptoms caused by the allergy. In continuous long-term treatment, the nasal mucosa should be inspected regularly e.g. every 6 months.</p><p>&nbsp;</p><p>Reduced liver function affects the elimination of corticosteroids, causing lower elimination rate and higher systemic exposure. Be aware of possible systemic side effects.</p><p>&nbsp;</p><p>Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations. Potential systemic effects may include Cushing&#39;s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children).</p><p>&nbsp;</p><p>Visual disturbance</p><p>&nbsp;</p><p>Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.</p><p>&nbsp;</p><p>Paediatric population</p><p>&nbsp;</p><p>The long-term effects of nasal glucocorticosteroids in children are not fully known. Physicians should closely follow the growth of children taking glucocorticosteroids for longer term by any route, and weigh the benefits of the glucocorticosteroid therapy against the possibility of growth suppression. If growth is slowed, therapy should be reviewed with the aim of reducing the dose of nasal corticosteroid, if possible, to the lowest dose at which effective control of symptoms is maintained. In addition, consideration should also be given to referring the patient to a paediatric specialist.</p><p>&nbsp;</p><p>Treatment with higher than recommended doses may result in clinically significant adrenal suppression. If there is evidence for higher than recommended doses being used, additional systemic corticosteroid cover should be considered during periods of stress or elective surgery.</p><p>&nbsp;</p><p>Co-treatment with CYP3A inhibitors, e.g. itraconazole, ketoconazole, HIV protease inhibitors and cobicistat-containing products is expected to increase the risk of systemic corticosteroid side effects. Therefore, the combination should be avoided unless the benefit outweighs this increased risk, in which case patients should be monitored for systemic corticosteroid side effects. This is of limited clinical importance for short-term (1-2 weeks) treatment with itraconazole or ketoconazole or other potent CYP3A inhibitors, but should be taken into consideration during long-term treatment. A reduction in the dose of budesonide should also be considered (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Budinide has not been observed to interact with any drug used for the treatment of rhinitis.</p><p>The metabolism of budesonide is primarily mediated by CYP3A enzymes. Co-treatment with CYP3A inhibitors, e.g. itraconazole, ketoconazole, HIV protease inhibitors and cobicistat-containing products, are expected to increase the risk of systemic side effects (see section 4.4). The combination of Budinide with potent CYP3A inhibitors should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side effects, in which case patients should be monitored for systemic corticosteroid side effects. If Budinide is co-administered with anti-fungals (such as itraconazole and ketoconazole), the period between treatments should be as long as possible. A reduction of the budesonide dose could be considered.</p><p>Raised plasma concentrations of and enhanced effects of corticosteroids have been observed in women also treated with oestrogens and contraceptive steroids, but no effect has been observed with Budinide and concomitant intake of low dose combination oral contraceptives.</p><p>Because adrenal function may be suppressed, an ACTH stimulation test for diagnosing pituitary insufficiency might show false results (low values).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>Results from prospective epidemiological studies and from worldwide post marketing experience indicate no increased risk for overall congenital malformations from the use of inhaled or intranasal budesonide during early pregnancy. As with other drugs the administration of Budinide during pregnancy requires that the benefits for the mother are weighed against the risk for the foetus.</p><p>&nbsp;</p><p><strong><u>Breast-feeding</u></strong></p><p>Budesonide is excreted in breast milk. However, at therapeutic doses of Budinide no effects on the breast fed child are anticipated. Budinide can be used during breast feeding.</p><p>&nbsp;</p><p>Maintenance treatment with inhaled Budinide (200 or 400 micrograms twice daily) in asthmatic nursing women results in negligible systemic exposure to budesonide in breast-fed infants.</p><p>&nbsp;</p><p>In a pharmacokinetic study, the estimated daily infant dose was 0.3% of the daily maternal dose for both dose levels, and the average plasma concentration in infants was estimated to be 1/600th of the concentrations observed in maternal plasma, assuming complete infant oral bioavailability. Budesonide concentrations in infant plasma samples were all less than the limit of quantification.</p><p>&nbsp;</p><p>Based on data from inhaled budesonide and the fact budesonide exhibits linear PK properties within the therapeutic dosage intervals after nasal, inhaled, oral and rectal administrations at therapeutic doses of budesonide, exposure to the breast-fed child is anticipated to be low.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Budinide has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Tabulated list of adverse reactions</strong></p><p>Adverse reactions, which have been associated with budesonide, are given below, listed by system organ class and frequency. Frequencies are defined as: very common (&ge;1/10), common (&ge;1/100 and &lt;1/10), uncommon (&ge;1/1000 and &lt;1/100), rare (&ge;1/10 000 and &lt;1/1000), very rare (&lt;1/10 000) and not known (cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td rowspan="2" style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Immediate and delayed hypersensitivity reactions including urticaria, rash, dermatitis angioedema and pruritus</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Anaphylactic reaction</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Signs and symptoms of systemic corticosteroid effects, including adrenal suppression and growth retardation</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Raised intraocular pressure or Glaucoma</p><p>Cataract</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Vision, blurred (see also section 4.4)</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Haemorrhagic secretion and epistaxis</p><p>Nasal Irritation (sneezing, stinging and dryness)</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Nasal septum perforation</p><p>Nasal ulcer</p><p>Dysphonia</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Ulceration of mucous membrane</p></td></tr><tr><td><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Muscle spasm</p></td></tr><tr><td><p>Injury, poisoning and procedural complications</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Contusion*</p></td></tr></tbody></table><p>&nbsp;</p><p>* based on mechanistic plausibility and extrapolation from other budesonide/corticosteroid formulations.</p><p>In rare cases, signs or symptoms of systemic glucocorticosteroid-side effects such as Cushing&#39;s syndrome, Cushingoid features, psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children), may occur with nasal glucocorticosteroids, probably depending on dose, exposure time, concomitant and previous corticosteroid exposure, and individual sensitivity (see section 4.4).</p><p><strong>Paediatric population</strong></p><p>Growth retardation has been reported in children receiving intranasal steroids. Due to the risk of growth retardation in the paediatric population, growth should be monitored as described in section 4.4.</p><p>&nbsp;</p><p><strong>To report any side effects</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Pharmacovigilance and Drug Safety Center (NPC)</p><p>o&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>o&nbsp;&nbsp; To call the executive management of vigilance and crisis management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340</p><p>o&nbsp;&nbsp; Toll-free: 8002490000</p><p>o&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>o&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute overdose with Budinide even in excessive doses, is not expected to be a clinical problem.</p><p>Inhalation of high doses of corticosteroids may lead to suppression of the hypothalamic-pituitary-adrenal (HPA) axis function.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Decongestants and other nasal preparations for topical use, corticosteroids. ATC code: R01A D05</p><p>Budesonide is a non-halogenated glucocorticosteroid with a high local anti-inflammatory action within the respiratory tract.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bioavailablity of oral budesonide in man is low (11-13%) due to an extensive first-pass metabolism in the liver.</p><p>The systemic availability of budesonide from Budinide, with reference to the metered dose is 33%. In adults, the maximal plasma concentration after administration of 256 micrograms budesonide from Budinide is 0.64 nM and is reached within 0.7 hours. The AUC after administration of 256 micrograms budesonide from Budinide is 2.7 nmolxh/L in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The acute toxicity of budesonide is low and of the same order of magnitude and type as that of the reference glucocorticoids studied (beclomethasone dipropionate, flucinolone acetonide). Results from subacute and chronic toxicity studies show that the systemic effects of budesonide are less severe than or similar to those observed after administration of the other glucocorticosteroids e.g. decreased body weight gain and atrophy of lymphoid tissues and adrenal cortex. An increased incidence of brain gliomas in male rats in a carcinogenicity study could not be verified in a repeat study, in which the incidence of gliomas did not differ between any of the groups on active treatment (budesonide, prednisolone, triamcinolone acetonide) and the control groups. Liver changes (primary hepatocellular neoplasms) found in male rats in the original carcinogenicity study were noted again in the repeat study with budesonide, as well as with the reference glucocorticosteroids. These effects are most probably related to a receptor effect and thus represent a class effect.</p><p>&nbsp;</p><p>Available clinical experience shows no indication that budesonide or other glucocorticosteroids induce brain gliomas or primary heptocellular neoplasms in man. Budesonide has been used successfully in the treatment of seasonal allergic rhinitis for several years.</p><p>&nbsp;</p><p>In animal reproduction studies, corticosteroids such as budesonide have been shown to induce malformations (cleft palate, skeletal malformations). However these animal experimental results do not appear to be relevant in humans at the recommended doses.</p><p>&nbsp;</p><p>Animal studies have also identified an involvement of excess prenatal glucocorticosteroids in increased risk for intrauterine growth retardation, adult cardiovascular disease and permanent changes in glucocorticoid receptor density, neurotransmitter turnover and behaviour at exposures below the teratogenic dose range.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Carboxymethylcellulose</p><p>Microcrystalline Cellulose</p><p>Potassium Sorbate</p><p>Glucose</p><p>Polysorbate 80</p><p>Disodium Edetate</p><p>Hydrochloric acid N</p><p>Purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
Use within 3 months of starting treatment.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.</p><p>Do not refrigerate or freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Packaged in amber coloured glass type III bottle with dispenser pump crimbed to the bottle, actuator &amp; cap containing white to off white suspension.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before using Budinide for the first time the nozzle must be primed (filled with the medicine). To do this the bottle is shaken and the protective cap removed. The bottle is then held upright and the nozzle pumped up and down several times (5-10 times) spraying into the air, until an even mist is seen. The priming effect remains for approximately 24 hours. If a longer period of time passes before the next dose is taken, the nozzle must be loaded with medicine again. This time it is sufficient to spray just once into the air.</p><p>a. The patient is then instructed to blow their nose. Next, the bottle needs to be shaken and the protective cap removed.</p><p>b. The bottle is then held upright, with one finger held on either side of the nozzle.</p><p>c. The tip of the nozzle is inserted into the nostril and the nozzle pressed down once (or more as instructed by the doctor). The spray is then administered into the other nostril in the same way. Note: it is not necessary to inhale at the same time as spraying.</p><p>d. The nozzle needs to be wiped with a clean tissue after use and the protective cap replaced. The bottle should be stored in an upright position.</p><p>e.&nbsp;<strong>Keeping the Budinide nozzle clean</strong></p><p>The plastic nozzle of Budinide should be cleaned regularly and at any time the spray of medicine is not coming out as it should. If this happens, first the nozzle should be checked to ensure that it is primed with medicine (see earlier). If, after the nozzle is primed again, the pump is still not working, the nozzle should be cleaned by using the following instructions:</p><p>The plastic nozzle is removed with a clean tissue and washed in warm, not hot, water. The nozzle is then rinsed thoroughly, dried and then replaced onto the top of the bottle. The nozzle should not be unblocked with a pin or other sharp object. After cleaning, the nozzle must be primed (filled with medicine) again before use.</p><p>No special requirements for disposal.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O.Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>